Oral Human Abuse Potential of Oxycodone DETERx®(Xtampza®ER)-Reference-Cited by-同舟云学术

Oral Human Abuse Potential of Oxycodone DETERx®(Xtampza®ER)

Published:2016-11-01 Issue:4 Volume:57 Page:500-512
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:The Journal of Clinical Pharmacology

Author:

Kopecky Ernest A.¹,Fleming Alison B.¹,Levy-Cooperman Naama²,O'Connor Melinda¹,M. Sellers Edward³

Affiliation:

1. Collegium Pharmaceutical Inc; Canton MA USA

2. Altreos Research Partners Inc; Toronto Ontario Canada

3. University of Toronto and DL Global Partners Inc; Toronto Ontario Canada

Funder

Collegium Pharmaceutical Inc

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference30 articles.

1. Long-acting opioids for chronic pain: pharmacotherapeutic opportunities to enhance compliance, quality of life, and analgesia;McCarberg;Am J Ther,2001

2. Benefits of extended-release opioid analgesic formulations in the treatment of chronic pain;Nicholson;Pain Pract,2009

3. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone);Pergolizzi;Pain Pract,2008

4. Effects of infusion rate of intravenously administered morphine on physiological, psychomotor, and self-reported measures in humans;Marsch;J Pharmacol Exp Ther,2001

5. Rate of increase of plasma drug level influences subjective response in humans;Wit;Psychopharmacology (Berl),1992

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A review on abuse-deterrent formulations: formulation technology and regulatory stands in approval process;Pharmaceutical Development and Technology;2024-09-03

2. Review of Opioid Abuse-Deterrent Formulations: Impact and Barriers to Access;Journal of Pain Research;2024-06

3. Oxycodone Extended-Release Capsule Utilization for Pain Management in a Cancer Palliative Care Clinic: A Retrospective Review;Journal of Pain & Palliative Care Pharmacotherapy;2023-09-13

4. Functional properties of thermally tampered poly(ethylene oxide);BioImpacts;2022-08-23

5. Pharmacovigilance Signals of the Opioid Epidemic over 10 Years: Data Mining Methods in the Analysis of Pharmacovigilance Datasets Collecting Adverse Drug Reactions (ADRs) Reported to EudraVigilance (EV) and the FDA Adverse Event Reporting System (FAERS);Pharmaceuticals;2022-05-27